Drawing for AXXIN

USPTO serial 79323460

AXXIN

Reviewed by CopyMark Law Group

Reg. 7134871Status 700Registered
Filing date
Status date
Registration date
Aug 15, 2023
Examiner
CORNWELL, ANDREA B
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AXXIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jason Paul Blair

Jason Paul Blair DYKEMA GOSSETT PLLC1301 K Street N.W.Suite 1100 WestWashington, DC 20005

Goods and services

ClassDescriptionStatusFirst use
009Scientific apparatus and instruments, namely, optical, isothermal, chromatographic, cardiographic, microfluidic, photometric, chemical, genetic, and biological sensors and instruments for measuring and analyzing molecular reagents, nucleic acid reagents, and immunoassay reagents for scientific testing purposes, namely, for identifying diseases or medical conditions via in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applications, and for testing for specific DNA, pathogens, antigens, viruses and bacteria, none of the foregoing goods for medical diagnostic or treatment purposes; recorded software, downloadable software, and recorded and downloadable operating system software for controlling or operating and configuring biomedical sensors and instruments, analyzing test and sample results, managing assay test workflow and protocol design, and compiling and exporting medical test data for scientific, diagnostic, and medical treatment purposes; none of the foregoing used in the field of dentistryACTIVE—
010Biomedical apparatus and instruments, namely, optical, isothermal, chromatographic, cardiographic, microfluidic, photometric, chemical, genetic, and biological sensors and instruments for measuring and analyzing molecular reagents, nucleic acid reagents, and immunoassay reagents for medical purposes, namely, for identifying diseases or medical conditions via in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applications, and for testing for specific DNA, pathogens, antigens, viruses and bacteria for medical diagnostic or treatment purposes; none of the foregoing used in the field of dentistryACTIVE—
040Custom manufacture of medical devices, namely, optical, isothermal, chromatographic, cardiographic, microfluidic, photometric, chemical, genetic, and biological sensors, instruments, and cartridges for measuring and analyzing molecular, nucleic acid, and immunoassay reagents using in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applications for identifying diseases or medical conditions, and for testing for specific DNA, pathogens, antigens, viruses and bacteria; information, advisory and consultancy services in relation to the aforementioned; none of the foregoing used in the field of dentistryACTIVE—
042Design and development of medical devices, namely, optical, isothermal, chromatographic, cardiographic, microfluidic, photometric, chemical, genetic, and biological sensors, instruments, and cartridges for measuring and analyzing molecular reagents, nucleic acid reagents, and immunoassay reagents for medical purposes, namely, for identifying diseases or medical conditions via in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applications, and for testing for specific DNA, pathogens, antigens, viruses and bacteria; design and development of computer hardware and software for controlling or operating and configuring biomedical sensors and instruments, analyzing test and sample results, managing assay test workflow and protocol design, and compiling and exporting medical test data for scientific, diagnostic, and treatment purposes; scientific research services; scientific laboratory services; medical research, analysis, and testing laboratories; none of the foregoing used in the field of dentistryACTIVE—
044Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic testing services; information, advisory and consultancy services in relation to the aforementioned; none of the foregoing used in the field of dentistryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 1, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 1, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 1, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 1, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 1, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 1, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 3, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 15, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 15, 2023FIMPFINAL DISPOSITION PROCESSED—
Nov 15, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 28, 2023LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Sep 10, 2023LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Aug 15, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 15, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 6, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 6, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 6, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 30, 2023GPNXNOTIFICATION PROCESSED BY IB—
May 30, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 30, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 10, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 10, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 10, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 25, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 25, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Apr 25, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 25, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 25, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 18, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 18, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 12, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 22, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 22, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 12, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 11, 2023LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Oct 30, 2022LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Oct 18, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 18, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 18, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 28, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 28, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 28, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 18, 2022RFNTREFUSAL PROCESSED BY IB—
Mar 31, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 31, 2022RFRRREFUSAL PROCESSED BY MPU—
Mar 1, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 28, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 18, 2022DOCKASSIGNED TO EXAMINER—
Oct 29, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 25, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 22, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance